Cargando…

Phospho-HDAC6 Gathers Into Protein Aggregates in Parkinson’s Disease and Atypical Parkinsonisms

HDAC6 is a unique histone deacetylase that targets cytoplasmic non-histone proteins and has a specific ubiquitin-binding activity. Both of these activities are required for HDAC6-mediated formation of aggresomes, which contain misfolded proteins that will ultimately be degraded via autophagy. HDAC6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzetti, Samanta, De Leonardis, Mara, Gagliardi, Gloria, Calogero, Alessandra Maria, Basellini, Milo Jarno, Madaschi, Laura, Costa, Ilaria, Cacciatore, Francesca, Spinello, Sonia, Bramerio, Manuela, Cilia, Roberto, Rolando, Chiara, Giaccone, Giorgio, Pezzoli, Gianni, Cappelletti, Graziella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324673/ https://www.ncbi.nlm.nih.gov/pubmed/32655357 http://dx.doi.org/10.3389/fnins.2020.00624

Ejemplares similares

α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson’s disease
por: Mazzetti, Samanta, et al.
Publicado: (2020)

Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization
por: Calogero, Alessandra Maria, et al.
Publicado: (2023)

Astrocytes expressing Vitamin D‐activating enzyme identify Parkinson’s disease
por: Mazzetti, Samanta, et al.
Publicado: (2022)

The Association between α-Synuclein and α-Tubulin in Brain Synapses
por: Amadeo, Alida, et al.
Publicado: (2021)

Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson’s Disease Patient Fibroblasts
por: Cartelli, Daniele, et al.
Publicado: (2012)

Correction: Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson’s Disease Patient Fibroblasts
por: Cartelli, Daniele, et al.
Publicado: (2012)

Glucocerebrosidase mutations in primary parkinsonism
por: Asselta, Rosanna, et al.
Publicado: (2014)

Microtubule Alterations Occur Early in Experimental Parkinsonism and The Microtubule Stabilizer Epothilone D Is Neuroprotective
por: Cartelli, Daniele, et al.
Publicado: (2013)

Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
por: Cereda, Emanuele, et al.
Publicado: (2017)

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study
por: Cilia, Roberto, et al.
Publicado: (2017)

Erratum to: Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
por: Cereda, Emanuele, et al.
Publicado: (2017)

DJ1 analysis in a large cohort of Italian early onset Parkinson Disease patients()
por: Sironi, Francesca, et al.
Publicado: (2013)

Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene
por: Doppler, Kathrin, et al.
Publicado: (2018)

Natural history of motor symptoms in Parkinson’s disease and the long-duration response to levodopa
por: Cilia, Roberto, et al.
Publicado: (2020)

The modern pre-levodopa era of Parkinson’s disease: insights into motor complications from sub-Saharan Africa
por: Cilia, Roberto, et al.
Publicado: (2014)

Role of Dietary Supplements in the Management of Parkinson’s Disease
por: Ciulla, Michele, et al.
Publicado: (2019)

Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic
por: Alberts, Jay L., et al.
Publicado: (2021)

Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson’s disease
por: Barrenschee, Martina, et al.
Publicado: (2017)

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease
por: Doppler, Kathrin, et al.
Publicado: (2017)

Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease
por: Garrido, Alicia, et al.
Publicado: (2022)

LRRK2 mutations in Parkinson's disease: Confirmation of a gender effect in the Italian population
por: Cilia, Roberto, et al.
Publicado: (2014)

TARDBP mutations in a cohort of Italian patients with Parkinson’s disease and atypical parkinsonisms
por: Tiloca, Cinzia, et al.
Publicado: (2022)

Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase
por: Lis, Pawel, et al.
Publicado: (2018)

HDAC6 Deficiency Has Moderate Effects on Behaviors and Parkinson’s Disease Pathology in Mice
por: Zhao, Jiayin, et al.
Publicado: (2023)

Vitamin D Status and Parkinson’s Disease
por: Barichella, Michela, et al.
Publicado: (2022)

Monitoring subthalamic oscillations for 24 hours in a freely moving Parkinson's disease patient
por: Arlotti, Mattia, et al.
Publicado: (2019)

Role of Lysosomal Gene Variants in Modulating GBA ‐Associated Parkinson's Disease Risk
por: Straniero, Letizia, et al.
Publicado: (2022)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Onset and mortality of Parkinson’s disease in relation to type II diabetes
por: Pezzoli, Gianni, et al.
Publicado: (2022)

Predictors of COVID-19 outcome in Parkinson's disease
por: Fasano, Alfonso, et al.
Publicado: (2020)

Impulse control disorders in Parkinson’s disease: seeking a roadmap toward a better understanding
por: Cilia, Roberto, et al.
Publicado: (2011)

Divergent Thinking in Parkinsonism: A Case–Control Study
por: Canesi, Margherita, et al.
Publicado: (2017)

Hypomania, Depression, Euthymia: New Evidence in Parkinson's Disease
por: Canesi, Margherita, et al.
Publicado: (2020)

Precision Medicine in Parkinson’s Disease: From Genetic Risk Signals to Personalized Therapy
por: Straccia, Giulia, et al.
Publicado: (2022)

A role for locus coeruleus in Parkinson tremor
por: Isaias, Ioannis U., et al.
Publicado: (2012)

Side effects induced by the acute levodopa challenge in Parkinson’s Disease and atypical parkinsonisms
por: Vasta, Rosario, et al.
Publicado: (2017)

Gait Initiation Impairment in Patients with Parkinson’s Disease and Freezing of Gait
por: Palmisano, Chiara, et al.
Publicado: (2022)

Association analysis of PARP1 polymorphisms with Parkinson’s disease
por: Brighina, Laura, et al.
Publicado: (2011)

Mass gatherings and mass gatherings health
por: Yezli, Saber, et al.
Publicado: (2016)

Diabetes and Risk of Parkinson’s Disease: A systematic review and meta-analysis
por: Cereda, Emanuele, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cv5fphck023kpn60vqcjgphsfq